Altered endosome biogenesis in prostate cancer has biomarker potential

Molecular Cancer Research

Volumn 12, Issue 12, 2014, Pages 1851-1862

  Johnson, Ian R D ^a   Parkinson Lawrence, Emma J ^a   Shandala, Tetyana ^a   Weigert, Roberto ^b   Butler, Lisa M ^c   Brooks, Doug A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; APPL1 PROTEIN; APPL2 PROTEIN; BIOLOGICAL MARKER; EARLY ENDOSOME ANTIGEN 1; LIMP2 PROTEIN; MESSENGER RNA; RAB PROTEIN; RAB5A PROTEIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; TRANSFERRIN RECEPTOR C; TUMOR MARKER; UNCLASSIFIED DRUG; APPL1 PROTEIN, HUMAN; CD71 ANTIGEN; LEUKOCYTE ANTIGEN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TFR2 PROTEIN, HUMAN;

ARTICLE; BASEMENT MEMBRANE; BIOGENESIS; CANCER PATIENT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LNCAP CELL LINE; MALE; MICROARRAY ANALYSIS; PROSTATE CANCER; PROTEIN EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; CELL LINE, TUMOR; ENDOSOMES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84919389401     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0074     Document Type: Article

References (51)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
3. Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2012;157:120-34.
4. Parachoniak CA, Park M. Dynamics of receptor trafficking in tumorigenicity. Trends Cell Biol 2012;22:231-40.
5. Hurley JH, Odorizzi G. Get on the exosome bus with ALIX. Trends Cell Biol 2012;14:654-5.
6. Hu CT, Wu JR, Wu WS. The role of endosomal signaling triggered by metastatic growth factors in tumor progression. Cell Signal 2013;25:1539-45.
7. Settembre C, Fraldi A, Medina DL, Ballabio A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 2013;14:283-96.
8. Boucrot E, Kirchhausen T. Endosomal recycling controls plasma membrane area during mitosis. Proc Natl Acad Sci U S A 2007;104:7939-44.
9. Palfy M, Remenyi A, Korcsmaros T. Endosomal crosstalk: meeting points for signaling pathways. Trends Cell Biol 2012;22:447-56.
10. Glunde K, Guggino SE, Solaiyappan M, Pathak AP, Ichikawa Y, Bhujwalla ZM. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 2003;5:533-45.
11. Stow JL, Murray RZ. Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor Rev 2013;24:227-39.
12. Henneberry MO, Engel G, Grayhack JT. Acid phosphatase. Urol Clin North Am 1979;6:629-41.
13. Quintero IB, Araujo CL, Pulkka AE, Wirkkala RS, Herrala AM, Eskelinen EL, et al. Prostatic acid phosphatase is not a prostate specific target. Cancer Res 2007;67:6549-54.
14. Johnson IR, Parkinson-Lawrence EJ, Butler LM, Brooks DA. Prostate cell lines as models for biomarker discovery: Performance of current markers and the search for new biomarkers. Prostate 2014;74:547-60.
15. Camacho L, Meca-Cortes O, Abad JL, Garcia S, Rubio N, Diaz A, et al. Acid ceramidase as a therapeutic target in metastatic prostate cancer. J Lipid Res 2013;54:1207-20.
16. Kuronita T, Eskelinen EL, Fujita H, Saftig P, Himeno M, Tanaka Y. A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology. J Cell Sci 2002;115:4117-31.
17. Huotari J, Helenius A. Endosome maturation. EMBO J 2011;30:3481-500.
18. Zerial M, McBride H. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001;2:107-17.
19. Jordens I, Marsman M, Kuijl C, Neefjes J. Rab proteins, connecting transport and vesicle fusion. Traffic 2005;6:1070-7.
20. Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer 2010;127:1-8.
21. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, et al. A gene network regulating lysosomal biogenesis and function. Science 2009;325:473-7.
22. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010;18:11-22.
23. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 2007;121:1424-32.
24. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.CA Cancer J Clin 2005;55:74-108.
25. Australian Institute of Health and Welfare (AIHW). Cancer in Australia 2010: an overview. Cancer series no. 60. Cat. no. CAN 56. Canberra: AIHW; 2010 Jan 1.
26. Roobol MJ, Haese A, Bjartell A. Tumour markers in prostate cancer III: biomarkers in urine. Acta Oncol 2011;50(Suppl 1):85-9.
27. Ploussard G, de laTaille A. Urine biomarkers in prostate cancer. Nat Rev Urol 2010;7:101-9.
28. Eberlin LS, Dill AL, Costa AB, Ifa DR, Cheng L, Masterson T, et al. Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Anal Chem 2010;82:3430-4.
29. Yao S, Ireland SJ, Bee A, Beesley C, Forootan SS, Dodson A, et al. Splice variant PRKC-zeta(-PrC) is a novel biomarker of human prostate cancer. Br J Cancer 2012;107:388-99.
30. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 1994;107:373-84.
31. + Exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 2009;10:737-53.
32. Steffan JJ, Cardelli JA. Thiazolidinediones induce Rab7-RILP -MAPK-dependent juxtanuclear lysosome aggregation and reduce tumor cell invasion. Traffic 2010;11:274-86.
33. Roshy S, Sloane BF, Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 2003;22:271-86.
34. Authier F, Kouach M, Briand G. Endosomal proteolysis of insulin-like growth factor-I at its C-terminal D-domain by cathepsin B. FEBS Lett 2005;579:4309-16.
35. Zaidi N, Maurer A, Nieke S, Kalbacher H. Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun 2008;376:5-9.
36. Deacon SW, Nascimento A, Serpinskaya AS, Gelfand VI. Regulation of bidirectional melanosome transport by organelle bound MAP kinase. Curr Biol 2005;15:459-63.
37. Pasini FS, Maistro S, Snitcovsky I, Barbeta LP, Rotea Mangone FR, Lehn CN, et al. Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma. Acta Oncol 2012;51:77-85.
38. Steffan JJ, Dykes SS, Coleman DT, Adams LK, Rogers D, Carroll JL, et al. Supporting a role for the GTPase Rab7 in prostate cancer progression. PLoS ONE 2014;9:e87882.
39. Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT. Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol 1990;143:381-5.
40. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, et al. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 2006;26:2373-86.
41. Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002;13:2276-88.
42. Puri C, Chibalina MV, Arden SD, Kruppa AJ, Kendrick-Jones J, Buss F. Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis. Oncogene 2010;29:188-200.
43. Fili N, Calleja V, Woscholski R, Parker PJ, Larijani B. Compartmental signal modulation: endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. Proc Natl Acad Sci U S A 2006;103:15473-8.
44. Lee JR, Hahn HS, Kim YH, Nguyen HH, Yang JM, Kang JS, et al. Adaptor protein containingPHdomain, PTBdomain and leucine zipper (APPL1) regulates the protein level of EGFR by modulating its trafficking. Biochem Biophys Res Commun 2011;415:206-11.
45. Wang C, Xin X, Xiang R, Ramos FJ, Liu M, Lee HJ, et al. Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem 2009;284:31608-15.
46. Yang L, Lin HK, Altuwaijri S, Xie S, Wang L, Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. J Biol Chem 2003;278:16820-7.
47. Broussard JA, Lin WH, Majumdar D, Anderson B, Eason B, BrownCM, et al. The endosomal adaptor protein APPL1 impairs the turnover of leading edge adhesions to regulate cell migration. Mol Biol Cell 2012;23:1486-99.
48. Chotard L, Mishra AK, Sylvain MA, Tuck S, Lambright DG, Rocheleau CE. TBC-2 regulates RAB-5/RAB-7-mediated endosomal trafficking in Caenorhabditis elegans. Mol Biol Cell 2010;21:2285-96.
49. Peralta ER, Martin BC, Edinger AL. Differential effects of TBC1D15 and mammalian Vps39 on Rab7 activation state, lysosomal morphology, and growth factor dependence. J Biol Chem 2010;285:16814-21.
50. Subramani D, Alahari SK. Integrin-mediated function of Rab GTPases in cancer progression. Mol Cancer 2010;9:312.
51. Liu AY, Roudier MP, True LD. Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile. Am J Pathol 2004;165:1543-56.